FOXO1 Rabbit Polyclonal Antibody
CAT#: TA323072
Anti-FOXO1 (Phospho-Ser256) Rabbit Polyclonal Antibody
Size: 25 ul
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 3800.00
| Cited in 7 publications. | 
                                                
                                                
                                                
                                                    CNY 300.00 
                                                    
                                                    CNY 1430.00
                                                
                                            
Specifications
| Product Data | |
| Applications | IF, IHC, WB | 
| Recommend Dilution | WB: 500-2000 WB positive control: Hela cell lysate IHC: 25-100 Positive control: Human ovarian cancer Predicted cell location: Cytoplasm and Nucleus | 
| Reactivity | Human, Mouse, Rat | 
| Modifications | Phospho-specific | 
| Host | Rabbit | 
| Clonality | Polyclonal | 
| Immunogen | Peptide sequence around phosphorylation site of serine 256 (A-A-S(p)-M-D) derived from Human FKHR. | 
| Isotype | IgG | 
| Formulation | PBS pH7.3, 0.05% NaN3, 50% glycerol | 
| Concentration | lot specific | 
| Purification | Antigen affinity purification | 
| Conjugation | Unconjugated | 
| Storage Condition | Store at -20°C as received. | 
| Predicted Protein Size | 70 kDa | 
| Gene Name | forkhead box O1 | 
| Database Link | |
| Background | This gene belongs to the forkhead family of transcription factors which are characterized by a distinct forkhead domain. The specific function of this gene has not yet been determined; however, it may play a role in myogenic growth and differentiation. Translocation of this gene with PAX3 has been associated with alveolar rhabdomyosarcoma. | 
| Synonyms | FKH1; FKHR; FOXO1A | 
| Reference Data | |
| Protein Families | Druggable Genome, Transcription Factors | 
| Protein Pathways | Insulin signaling pathway, Pathways in cancer, Prostate cancer | 
Citations (7)
| The use of this Antibodies has been cited in the following citations: | 
|---|
| Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation
                                                ,Ge, C;Xu, M;Qin, Y;Gu, T;Lou, D;Li, Q;Hu, L;Nie, X;Wang, M;Tan, J;,
                                                Food Funct
                                                ,PubMed ID 31074472
                                                [FOXO1] | 
| The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
                                                ,Ji, YX;Huang, Z;Yang, X;Wang, X;Zhao, LP;Wang, PX;Zhang, XJ;Alves-Bezerra, M;Cai, L;Zhang, P;Lu, YX;Bai, L;Gao, MM;Zhao, H;Tian, S;Wang, Y;Huang, ZX;Zhu, XY;Zhang, Y;Gong, J;She, ZG;Li, F;Cohen, DE;Li, H;,
                                                Nat. Med.
                                                ,PubMed ID 29291351
                                                [FOXO1] | 
| The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
                                                ,Zhang, P;Wang, PX;Zhao, LP;Zhang, X;Ji, YX;Zhang, XJ;Fang, C;Lu, YX;Yang, X;Gao, MM;Zhang, Y;Tian, S;Zhu, XY;Gong, J;Ma, XL;Li, F;Wang, Z;Huang, Z;She, ZG;Li, H;,
                                                Nat. Med.
                                                ,PubMed ID 29227477
                                                [FOXO1] | 
| Inhibition of Miro1 disturbs mitophagy and pancreatic β-cell function interfering insulin release via IRS-Akt-Foxo1 in diabetes
                                                ,Chen, L;Liu, C;Gao, J;Xie, Z;Chan, LWC;Keating, DJ;Yang, Y;Sun, J;Zhou, F;Wei, Y;Men, X;Yang, S;,
                                                Oncotarget
                                                ,PubMed ID 29207597
                                                [FOXO1] | 
| Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.
                                                ,null,
                                                Nature medicine
                                                ,PubMed ID 28218919
                                                [FOXO1] | 
| The novel intracellular protein CREG inhibits hepatic steatosis, obesity and insulin resistance
                                                ,Zhang, QY;Zhao, LP;Tian, XX;Yan, CH;Li, Y;Liu, YX;Wang, PX;Zhang, XJ;Han, YL;,
                                                Hepatology
                                                ,PubMed ID 28508477
                                                [FOXO1] | 
| Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
                                                ,null,
                                                Nature Communications
                                                ,PubMed ID 26882989
                                                [FOXO1] | 
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 

 
                         
                             
                             
                             
                            
 
        